4/A
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001618835-18-000128
Options or other derivatives
- Chief Financial Officer acquired 103,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
File Justin J. · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-11-28 | Grant or award : show line 1 in the form Stock option (right to buy) | +103,500 | 103,500 | D |
Loading xslF345X03/wf-form4a_154385943828394.xml…